389 related articles for article (PubMed ID: 23026513)
1. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action.
Park JH; Hwang I; Hwang SH; Han H; Ha H
Diabetes Res Clin Pract; 2012 Dec; 98(3):465-73. PubMed ID: 23026513
[TBL] [Abstract][Full Text] [Related]
2. Delayed treatment with human umbilical cord blood-derived stem cells attenuates diabetic renal injury.
Park JH; Park J; Hwang SH; Han H; Ha H
Transplant Proc; 2012 May; 44(4):1123-6. PubMed ID: 22564642
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
5. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
[TBL] [Abstract][Full Text] [Related]
6. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide.
Yuan P; Xue H; Zhou L; Qu L; Li C; Wang Z; Ni J; Yu C; Yao T; Huang Y; Wang R; Lu L
Nephrol Dial Transplant; 2011 Jul; 26(7):2119-26. PubMed ID: 21208996
[TBL] [Abstract][Full Text] [Related]
7. Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis.
Tsuda H; Yamahara K; Ishikane S; Otani K; Nakamura A; Sawai K; Ichimaru N; Sada M; Taguchi A; Hosoda H; Tsuji M; Kawachi H; Horio M; Isaka Y; Kangawa K; Takahara S; Ikeda T
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1004-13. PubMed ID: 20739390
[TBL] [Abstract][Full Text] [Related]
8. Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal stem cells on the development of renal ischemia-reperfusion injury in mice.
Jang HR; Park JH; Kwon GY; Lee JE; Huh W; Jin HJ; Choi SJ; Oh W; Oh HY; Kim YG
Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1149-61. PubMed ID: 25143451
[TBL] [Abstract][Full Text] [Related]
9. β-Casomorphin-7 attenuates the development of nephropathy in type I diabetes via inhibition of epithelial-mesenchymal transition of renal tubular epithelial cells.
Zhang W; Miao J; Ma C; Han D; Zhang Y
Peptides; 2012 Aug; 36(2):186-91. PubMed ID: 22687367
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells transplantation mildly ameliorates experimental diabetic nephropathy in rats.
Zhou H; Tian HM; Long Y; Zhang XX; Zhong L; Deng L; Chen XH; Li XQ
Chin Med J (Engl); 2009 Nov; 122(21):2573-9. PubMed ID: 19951572
[TBL] [Abstract][Full Text] [Related]
11. Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment.
Li Y; Liu J; Liao G; Zhang J; Chen Y; Li L; Li L; Liu F; Chen B; Guo G; Wang C; Yang L; Cheng J; Lu Y
Int J Mol Med; 2018 May; 41(5):2629-2639. PubMed ID: 29484379
[TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) inhibit the proliferation of K562 (human erythromyeloblastoid leukaemic cell line).
Fonseka M; Ramasamy R; Tan BC; Seow HF
Cell Biol Int; 2012 Sep; 36(9):793-801. PubMed ID: 22335239
[TBL] [Abstract][Full Text] [Related]
13. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
Kunter U; Rong S; Djuric Z; Boor P; Müller-Newen G; Yu D; Floege J
J Am Soc Nephrol; 2006 Aug; 17(8):2202-12. PubMed ID: 16790513
[TBL] [Abstract][Full Text] [Related]
14. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.
Ezquer F; Ezquer M; Simon V; Pardo F; Yañez A; Carpio D; Conget P
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1354-65. PubMed ID: 19822294
[TBL] [Abstract][Full Text] [Related]
15. Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats.
Deepa B; Venkatraman Anuradha C
Toxicol Mech Methods; 2013 May; 23(4):223-34. PubMed ID: 23193997
[TBL] [Abstract][Full Text] [Related]
16. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
17. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.
Seo JY; Park J; Yu MR; Kim YS; Ha H; Lee HB
Am J Nephrol; 2009; 30(6):481-90. PubMed ID: 19786738
[TBL] [Abstract][Full Text] [Related]
18. FK506 ameliorates renal injury in early experimental diabetic rats induced by streptozotocin.
Qi XM; Wu YG; Liang C; Zhang P; Dong J; Ren KJ; Zhang W; Fang F; Shen JJ
Int Immunopharmacol; 2011 Oct; 11(10):1613-9. PubMed ID: 21640200
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration.
Lv SS; Liu G; Wang JP; Wang WW; Cheng J; Sun AL; Liu HY; Nie HB; Su MR; Guan GJ
Int Immunopharmacol; 2013 Oct; 17(2):275-82. PubMed ID: 23791972
[TBL] [Abstract][Full Text] [Related]
20. Preventive effects of rutin on the development of experimental diabetic nephropathy in rats.
Hao HH; Shao ZM; Tang DQ; Lu Q; Chen X; Yin XX; Wu J; Chen H
Life Sci; 2012 Nov; 91(19-20):959-67. PubMed ID: 23000098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
